This inventor holds 4 USPTO granted patents. Top assignee: Shionogi Company Limited. Active years: 2008-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008-2012
Title: Kiyoshi Nagata: Innovator in Pharmaceutical Compounds
Introduction
Kiyoshi Nagata is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in enhancing the expression of apolipoprotein AI. With a total of 4 patents to his name, Nagata's work has implications for medical advancements.
Latest Patents
Nagata's latest patents include a method of enhancing the expression of apolipoprotein AI using olefin derivatives. This patent provides compounds that enhance the expression of apoAI, featuring specific chemical formulas that include various aromatic groups and linkers. Another notable patent focuses on the utilities of amide compounds, which are also aimed at enhancing the expression of apoAI and are intended for use as medicaments.
Career Highlights
Kiyoshi Nagata is currently employed at Shionogi & Company Limited, where he continues to innovate in the pharmaceutical sector. His work is characterized by a deep understanding of chemical compounds and their applications in medicine.
Collaborations
Nagata has collaborated with notable coworkers such as Teruo Yamamori and Natsuki Ishizuka, contributing to a dynamic research environment that fosters innovation.
Conclusion
Kiyoshi Nagata's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a key innovator. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile